Drug or treatment

Dasatinib clinical trials

• 9Clinical trials
• 18Countries

Newest trials

All recruiting trials (9)

• Dasatinib to Try Lower Hidden HIV in People on ART

  We’re testing if the drug dasatinib can help reduce the hidden HIV reservoir in people on effective ART.

  Recruiting at 3 sites Phase 1 National Institute of Allergy and Infectious Diseases (NIAID) · Chicago, Illinois and 2 other locations · NCT07342491

• Dasatinib plus ropeginterferon for newly diagnosed chronic myeloid leukemia in chronic phase

  This study tests whether the drug combination dasatinib and ropeginterferon can help control chronic myeloid leukemia in adults with newly diagnosed disease.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT07269470

• Sequenced or combined dasatinib, quercetin, fisetin, and temozolomide for adults with previously treated glioma and remaining tumor

  This trial will try different sequences or combinations of dasatinib, the plant compounds quercetin and fisetin, and the chemotherapy temozolomide to see if they are safe and help adults with previously treated glioma that still has residual tumor.

  Recruiting Early Phase 1 Mayo Clinic · Rochester, Minnesota · NCT07025226

• Dasatinib and quercetin plus preparation chemotherapy before CAR-T for relapsed or refractory multiple myeloma

  This phase II test will see whether adding dasatinib and quercetin to preparation chemotherapy and CAR-T cell therapy helps people with relapsed or refractory multiple myeloma.

  Recruiting Phase 2 Mayo Clinic · Rochester, Minnesota · NCT06940297

• Improving treatment responses in children with T-cell leukemia or lymphoma

  This study is testing if adding two new drugs to standard chemotherapy can help children and young adults with T-cell leukemia or lymphoma have better treatment outcomes.

  Recruiting at 4 sites Phase 2 St. Jude Children's Research Hospital · San Diego, California and 3 other locations · NCT06390319

• Combining blinatumomab with dasatinib or imatinib plus chemotherapy for young people with Ph+ or ABL-class Ph-like B‑ALL

  This pilot will see if adding three cycles of blinatumomab and a continuous tyrosine kinase inhibitor (dasatinib or imatinib) to a modified chemotherapy plan helps children, adolescents, and young adults with Ph+ or ABL-class Ph-like B‑ALL stay in remission longer.

  Recruiting at 159 sites Phase 2 National Cancer Institute (NCI) · Birmingham, Alabama and 160 other locations · NCT06124157

• Dasatinib and venetoclax with dexamethasone, cyclophosphamide, and cytarabine for children and young adults with relapsed or refractory ALL/LBL with MAPK/SRC changes

  This treatment tests whether adding dasatinib and venetoclax to dexamethasone, cyclophosphamide, and cytarabine helps children and young people (up to 21) whose relapsed or refractory acute lymphoblastic leukemia or lymphoblastic lymphoma have specific MAPK/SRC pathway changes.

  Recruiting at 2 sites Phase 1/2 Princess Maxima Center for Pediatric Oncology · Vienna and 32 other locations · NCT05751044

• Combination treatment for BCR-ABL positive B-cell leukemia and chronic myeloid leukemia

  This study is testing a new combination treatment for people with BCR-ABL positive B-cell leukemia or chronic myeloid leukemia to see if it helps them feel better and works well with existing medications.

  Recruiting at 4 sites Phase 1 Dana-Farber Cancer Institute · Chicago, Illinois and 3 other locations · NCT03595917

• Using ponatinib for patients with chronic myeloid leukemia who didn't respond to other treatments

  This study is testing if ponatinib can help people with chronic myeloid leukemia who didn't respond to other treatments feel better and improve their health.

  Recruiting Phase 2 M.D. Anderson Cancer Center · Houston, Texas · NCT01746836

Quick answers

How many clinical trials of Dasatinib are recruiting right now?

9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 18 countries. The most sites are in United States (8 trials), Australia (1 trial), Canada (1 trial), Puerto Rico (1 trial), Austria (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 5, Phase 1: 2, Early Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →